23andMe Launches Rare Diseases Study

August 22, 2022
Leveraging its innovative research platform, 23andMe launched a Rare Disease Study, looking first at five rare conditions with the hopes of identifying new treatments and insights for these hard to study diseases. Researchers will start by studying systemic sclerosis, ANCA-associated vasculitis, pemphigus vulgaris, and dermatomyositis. 
Read More

Recruitment Goal Met for Systemic Sclerosis Genetic Study

August 11, 2022
In late 2020, 23andMe launched a genetic study of systemic sclerosis, a rare autoimmune disease that results in the hardening and thickening of the skin and other organs. Within 18...
Read More

23andMe Launches Sarcoidosis Study

April 30, 2022
Diseases are considered rare if they affect fewer than 200,000 in the United States, but collectively rare diseases — there are nearly 7,000 — are more common than we realize,...
Read More

Talking About Rare Disease with Senior Scientist Suyash Shringarpure

September 14, 2021
23andMe senior scientist in statistical genetics, Suyash Shringarpure, Ph.D. talks about 23andMe's research model and how it offers a surprising opportunity in the study of rare diseases.
Read More

Living with Scleroderma

August 06, 2021
When Melissa Tarantino talks about facing challenges every day to her special needs students at a middle school near Sacramento, they listen. They all are aware that she knows what...
Read More

A Conversation with the Scleroderma Research Foundation’s Gloria Blecha

July 26, 2021
Systemic sclerosis, a form of scleroderma, is a rare disease that causes the hardening of the body’s connective tissue. Gloria Blecha, the Director of Community Engagement at the Scleroderma Research...
Read More

Living with Idiopathic Pulmonary Fibrosis

June 24, 2021
Recently we chatted with Bill Vick, founder of PF Warriors, a non-profit group for people living with pulmonary fibrosis, including idiopathic pulmonary fibrosis (IPF). Being diagnosed with IPF, as with...
Read More

New Insights into the Use of Genetics to Study Rare Disease

June 21, 2021
Researchers at 23andMe described what is believed to be the largest genomic study of rare diseases ever done in a groundbreaking new paper. The study offers up a potential alternative method for gaining insight into these challenging-to-study conditions.
Read More

Scientists uncover new information about how hard-to-treat genetic diseases are inherited

March 25, 2021
A new study by scientists at 23andMe, the Hospital for Sick Children (SickKids), and the University of Toronto offers insight into how the nuclear genome controls the emergence of mutations...
Read More

23andMe to Study Systemic Sclerosis

November 10, 2020
23andMe recently launched a genetic study of systemic sclerosis, a rare autoimmune disease that results in the hardening and thickening of the skin and other organs, for which there is...
Read More